Literature DB >> 18505839

Contacts between membrane proximal regions of the PDGF receptor ectodomain are required for receptor activation but not for receptor dimerization.

Yan Yang1, Satoru Yuzawa, Joseph Schlessinger.   

Abstract

The mechanism of PDGF-receptor beta (PDGFRbeta) activation was explored by analyzing the properties of mutant receptors designed based on the crystal structure of the extracellular region of the related receptor tyrosine kinase KIT/stem cell factor receptor. Here, we demonstrate that PDGF-induced activation of a PDGFRbeta mutated in Arg-385 or Glu-390 in D4 (the fourth Ig-like domain of the extracellular region) was compromised, resulting in impairment of a variety of PDGF-induced cellular responses. These experiments demonstrate that homotypic D4 interactions probably mediated by salt bridges between Arg-385 and Glu-390 play an important role in activation of PDGFRbeta and all type III receptor tyrosine kinases. We also used a chemical cross-linking agent to covalently cross-link PDGF-stimulated cells to demonstrate that a Glu390Ala mutant of PDGFRbeta undergoes typical PDGF-induced receptor dimerization. However, unlike WT PDGFR that is expressed on the surface of ligand-stimulated cells in an active state, PDGF-induced Glu390Ala dimers are inactive. Although the conserved amino acids that are required for mediating D4 homotypic interactions are crucial for PDGFRbeta activation, these interactions are dispensable for PDGFRbeta dimerization. Moreover, PDGFRbeta dimerization is necessary but not sufficient for tyrosine kinase activation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18505839      PMCID: PMC2409387          DOI: 10.1073/pnas.0802896105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Kit receptor dimerization is driven by bivalent binding of stem cell factor.

Authors:  M A Lemmon; D Pinchasi; M Zhou; I Lax; J Schlessinger
Journal:  J Biol Chem       Date:  1997-03-07       Impact factor: 5.157

2.  Role of immunoglobulin-like domains 2-4 of the platelet-derived growth factor alpha-receptor in ligand-receptor complex assembly.

Authors:  K Miyazawa; G Bäckström; O Leppänen; C Persson; C Wernstedt; U Hellman; C H Heldin; A Ostman
Journal:  J Biol Chem       Date:  1998-09-25       Impact factor: 5.157

3.  A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes.

Authors:  D S Ory; B A Neugeboren; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

4.  Dimerization of B-type platelet-derived growth factor receptors occurs after ligand binding and is closely associated with receptor kinase activation.

Authors:  C H Heldin; A Ernlund; C Rorsman; L Rönnstrand
Journal:  J Biol Chem       Date:  1989-05-25       Impact factor: 5.157

5.  The PDGF alpha receptor is required for neural crest cell development and for normal patterning of the somites.

Authors:  P Soriano
Journal:  Development       Date:  1997-07       Impact factor: 6.868

6.  Three-dimensional structure of dimeric human recombinant macrophage colony-stimulating factor.

Authors:  J Pandit; A Bohm; J Jancarik; R Halenbeck; K Koths; S H Kim
Journal:  Science       Date:  1992-11-20       Impact factor: 47.728

7.  Demonstration of epidermal growth factor-induced receptor dimerization in living cells using a chemical covalent cross-linking agent.

Authors:  C Cochet; O Kashles; E M Chambaz; I Borrello; C R King; J Schlessinger
Journal:  J Biol Chem       Date:  1988-03-05       Impact factor: 5.157

8.  Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice.

Authors:  P Soriano
Journal:  Genes Dev       Date:  1994-08-15       Impact factor: 11.361

9.  The fourth immunoglobulin domain of the stem cell factor receptor couples ligand binding to signal transduction.

Authors:  J M Blechman; S Lev; J Barg; M Eisenstein; B Vaks; Z Vogel; D Givol; Y Yarden
Journal:  Cell       Date:  1995-01-13       Impact factor: 41.582

10.  Crystal structure of human platelet-derived growth factor BB.

Authors:  C Oefner; A D'Arcy; F K Winkler; B Eggimann; M Hosang
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

View more
  33 in total

1.  Structures of a platelet-derived growth factor/propeptide complex and a platelet-derived growth factor/receptor complex.

Authors:  Ann Hye-Ryong Shim; Heli Liu; Pamela J Focia; Xiaoyan Chen; P Charles Lin; Xiaolin He
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-02       Impact factor: 11.205

Review 2.  Functional autoantibodies in systemic sclerosis.

Authors:  Jeannine Günther; Judith Rademacher; Jakob M van Laar; Elise Siegert; Gabriela Riemekasten
Journal:  Semin Immunopathol       Date:  2015-08-21       Impact factor: 9.623

3.  Structural basis for KIT receptor tyrosine kinase inhibition by antibodies targeting the D4 membrane-proximal region.

Authors:  Andrey V Reshetnyak; Bryce Nelson; Xiarong Shi; Titus J Boggon; Alevtina Pavlenco; Elizabeth M Mandel-Bausch; Francisco Tome; Yoshihisa Suzuki; Sachdev S Sidhu; Irit Lax; Joseph Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-14       Impact factor: 11.205

Review 4.  The emerging complexity of PDGFRs: activation, internalization and signal attenuation.

Authors:  Madison A Rogers; Katherine A Fantauzzo
Journal:  Biochem Soc Trans       Date:  2020-06-30       Impact factor: 5.407

Review 5.  Extracellular assembly and activation principles of oncogenic class III receptor tyrosine kinases.

Authors:  Kenneth Verstraete; Savvas N Savvides
Journal:  Nat Rev Cancer       Date:  2012-10-18       Impact factor: 60.716

6.  Suppression of EGFR endocytosis by dynamin depletion reveals that EGFR signaling occurs primarily at the plasma membrane.

Authors:  Leiliane P Sousa; Irit Lax; Hongying Shen; Shawn M Ferguson; Pietro De Camilli; Joseph Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-27       Impact factor: 11.205

Review 7.  Targeting extracellular domains D4 and D7 of vascular endothelial growth factor receptor 2 reveals allosteric receptor regulatory sites.

Authors:  Caroline A C Hyde; Alexandra Giese; Edward Stuttfeld; Johan Abram Saliba; Denis Villemagne; Thomas Schleier; H Kaspar Binz; Kurt Ballmer-Hofer
Journal:  Mol Cell Biol       Date:  2012-07-16       Impact factor: 4.272

8.  Structure, domain organization, and different conformational states of stem cell factor-induced intact KIT dimers.

Authors:  Yarden Opatowsky; Irit Lax; Francisco Tomé; Franziska Bleichert; Vinzenz M Unger; Joseph Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-21       Impact factor: 11.205

9.  Distinct cellular properties of oncogenic KIT receptor tyrosine kinase mutants enable alternative courses of cancer cell inhibition.

Authors:  Xiarong Shi; Leiliane P Sousa; Elizabeth M Mandel-Bausch; Francisco Tome; Andrey V Reshetnyak; Yaron Hadari; Joseph Schlessinger; Irit Lax
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-01       Impact factor: 11.205

10.  Direct contacts between extracellular membrane-proximal domains are required for VEGF receptor activation and cell signaling.

Authors:  Yan Yang; Peng Xie; Yarden Opatowsky; Joseph Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.